As the AHA and its members continue to address maternal mortality, the association today voiced support for the Joint Commission’s recently proposed standards for perinatal safety. “Specifically, we support the Joint Commission’s focus on evidence-based procedures and responses that will ensure the most medically appropriate and effective course of treatment for those individuals diagnosed with either maternal hemorrhages or severe hypertension/preeclampsia,” AHA wrote. “In addition, we support the proposed requirement for education of staff, and believe conducting complication-specific training and drills will better prepare providers to act effectively and efficiently when these situations arise. Further, we support the proposed provisions to provide patients and their families with the necessary educational materials to recognize symptoms that require immediate care as another important safeguard in this process.” For more on how hospitals are working to advance better health for mothers and babies, visit https://www.aha.org/better-health-for-mothers-and-babies.

Related News Articles

Headline
A Health Affairs study on the decline of obstetric services in rural and urban hospitals nationwide from 2010-2022 found that seven states had at least 25% of…
Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…
Headline
A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the importance of board members…
Headline
To help hospitals across the country improve sepsis care, the Centers for Disease Control and Prevention created the Hospital Sepsis Program Core Elements,…
Headline
The American Society for Health Care Engineering July 1 announced 87 health care facilities as winners of the 2025 Energy to Care Sustainability Champions…
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…